Biosimilars Market Will Witness Enhanced Demand In End-use Industries Till 2024: Grand View Research, Inc.

Aug 25, 2016

According to report published by Grand View Research, Inc., global biosimilars market will reach $41.7 billion by 2024, market is expected to grow at rapid pace as blockbuster biologics are approaching patent expiration; and thus, creating a huge potential for similar biological medicinal products.

San Francisco, California, United States - August 25, 2016 /MarketersMedia/ —

The biosimilars market is expected to reach USD 41.7 billion by 2024, according to a new report by Grand View Research, Inc. The global biosimilars market is anticipated to witness a marked growth during the period of 2016 to 2024. The most significant factor leading to the growth of this industry is the fact that major biological drugs are nearing the patent cliff. Further, the lower cost of these drugs as compared to the patented biologics, the increasing encumbrance to cut down healthcare costs across the medical systems in the world, and the favorable clinical outcomes demonstrated through clinical trials for the biosimilar drugs is expected to boost the industry.
For the purpose of this study, the major countries considered are the U.S., Canada, the UK, Germany, India, China, Brazil, and Russia. It was estimated that in 2015, Europe accounted for the largest market share of the global biosimilars market, followed by Asia Pacific.
The industry is segmented on the basis of type of products and applications. With regard to the product type, the recombinant non-glycosylated segment is projected to flourish rapidly during the study period. On the other hand, the recombinant glycosylated proteins segment is estimated to grow at a significant CAGR during the period 2015 to 2024 due to the increasing, wide spread incidence of cancer cases (24 million by 2035), which is identified as the crucial factor driving the growth of this sector.

Access full research report: http://www.grandviewresearch.com/industry-analysis/biosimilars-market

Key findings

• North America is anticipated to be the fastest growing market during the forecast period. The biosimilars market has gained significant momentum in the U.S., presenting new opportunities for R&D and the manufacturing sector of biosimilars.
• The European market is the most advanced one as it has been the first to formulate a regulatory pathway and adopt the use of biosimilars for more than 8 years now. Germany accounts for the maximum share in the biosimilars industry, followed by the rest of the European countries (UK, France, Spain, and Italy).
• The Asia Pacific market is expected to witness a lucrative growth during the period 2015 to 2024. India and China are the key countries identified that are expected to lead the industry growth in the study period.
• The market for oncology is estimated to soar at a rapid pace in accordance with the increasing incidence of cancer cases in the world. Additionally, the demand for cost-effective cancer treatments is expected to further fuel the industry growth.
• The biosimilars market comprises several local as well as global players. Some major players of this market include Amgen, Inc., Beacon Ltd., Tea Pharmaceutical Industries Ltd., Merck & Co., Milan, Inc., Dr. Reddy’s Laboratories, Inc., Sandoz, Inc., and Celltrion Healthcare Co., Ltd.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/pharmaceuticals

Market Segments:

Biosimilars Market, by Product (Revenue, USD Million, 2013 - 2024)
• Recombinant Non-Glycosylated Proteins
• Insulin
• Human Growth Hormones
• Granulocyte Colony-stimulating Factor (G-CSF)
• Interferons
• Recombinant Glycosylated Proteins
• Erythropoietin
• Monoclonal Antibodies
• Follitropin
Biosimilars Market, by Application (Revenue, USD Million, 2013 - 2024)
• Oncology
• Blood Disorders
• Growth Hormone Deficiency
• Chronic and Autoimmune Disorders
• Others
Biosimilars Market, by Region (Revenue, USD Million, 2013 - 2024)
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• China
• India
• Rest of the World
• Brazil
• Russia

Access press release of this research report: http://www.grandviewresearch.com/press-release/global-biosimilars-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services.

For more information, please visit http://www.grandviewresearch.com/industry-analysis/biosimilars-market

Contact Info:
Name: Sherry James
Organization: Grand View Research, Inc.
Address: 28 2nd Street, Suite 3036, San Francisco, California, 94105
Phone: 1-415-349-0058

Source: http://marketersmedia.com/biosimilars-market-will-witness-enhanced-demand-in-end-use-industries-till-2024-grand-view-research-inc/129487

Release ID: 129487

More News

article.head.headline
Sep 25, 2026
Percy Hynes White & Jeff Wahlberg Lead Lovers-On-The-Run Thriller ‘Crime Novella’, Roland Emmerich Exec-Producing & First Look Revealed

EXCLUSIVE: Percy Hynes White (My Old Ass), Jeff Wahlberg (Euphoria), Zlatko Burić (Triangle of Sadness), Bobby Soto (The Tax Collector) and Ava del Cielo (House of Cards) have been cast in writer-director Omar de Soto’s feature directorial debut, Crime Novella, which was shot on 35mm film. Written, directed and produced by de Soto, the romance […]

article.head.headline
Sep 25, 2026
US rapper Macklemore announces 'Free Palestine' tour after Ed Sheeran saga

PRESS REVIEW – Friday, September 25: There's anticipation and excitement in France as Pope Leo XIV embarks on the first papal visit to France in 18 years. It comes at a time of renewed Catholic faith among young French people. Also, we look at reactions after Italy's new legislation banning full-face Islamic headwear from schools. Plus: US rapper Macklemore announces a new "Free Palestine" tour that will raise funds for humanitarian groups.

article.head.headline
Sep 25, 2026
Sharon Stone addresses 'Euphoria' co-star Sydney Sweeney's ad controversy

Sharon Stone addresses ‘Euphoria’ co-star Sydney Sweeny’s ad controversySharon Stone believes Sydney Sweeney should "take responsibility" for her controversial Novig advertisement.The 29-year-old actress has faced a huge backlash from female athletes over the campaign, in which...

article.head.headline
Sep 25, 2026
Block the Merger Coalition Asks Court to Reject Paramount’s Settlement With States Over Warner Bros. Deal

A coalition of groups under the Block the Merger banner have filed an amicus brief – a third party representation in a court case – opposing the Paramount Skydance-Warner Bros. Discovery merger. The brief was filed late Thursday by Free Press, the Committee for the First Amendment, the Freedom of the Press Foundation, the Future […]

article.head.headline
Sep 25, 2026
Meghan Markle warns Prince William not to 'stand in her way'

Meghan Markle warns Prince William not to 'stand in her way'Meghan Markle is reportedly "furious" with Prince William after an insider claimed that the Prince of Wales pushed King Charles to clarify her royal status. “The latest statement from the Palace was very much pushed by William...

article.head.headline
Sep 25, 2026
Oscars: Denmark Selects May el-Toukhy’s Golden Lion Winner ‘Woman Unknown’ for International Feature Race

May el-Toukhy’s “Woman Unknown” as be chosen as Denmark’s official entry for the international feature film race at the Oscars. “Woman Unknown” just won the Golden Lion at the Venice Film Festival from a jury presided over by Maggie Gyllenhaall. El-Toukhy was the sole female director in competition at this year’s Venice fest. In addition […]

article.head.headline
Sep 25, 2026
Tales Of Syria’s Disappeared; Lebanese Wartime Adoption & Palestinian Mental Health Set For Cinemed-Aflamuna Project Incubator

France’s Montpellier Mediterranean Film Festival, also known as Cinemed, and Beirut-based Arab cinema platform Aflamuna have unveiled the selection for their fifth project incubator event, which will take place within the framework of the festival in October. The initiative, bannered the Aflamuna x Cinemed Encounters and supporting Arab filmmakers from across the Middle East and […]

article.head.headline
Sep 25, 2026
Dakota Johnson addresses 'pressure' of starring in 'Verity'

Dakota Johnson addresses ‘pressure’ of starring in ‘Verity’Dakota Johnson has admitted she felt a level of “pressure” starring in the film adaptation of Colleen Hoover’s Verity.The psychological romantic thriller novel, released in 2018, has sold more than...

article.head.headline
Sep 25, 2026
32 Things to Do for Halloween in New York City

During spooky season, keep it creepy with costume parades, witches on Wall Street and headless horsemen in the Hudson Valley.

article.head.headline
Sep 25, 2026
In ‘Basic Pistol,’ a Sociologist Finds Hidden Lessons in Gun Training

More than just instruction on how to use a weapon, the courses teach a way of life, the sociologist Harel Shapira argues in “Basic Pistol.”

article.head.headline
Sep 25, 2026
Filippo Bernardini Scammed the Book Business for Years. Is He Back?

The man who admitted to stealing hundreds of manuscripts swore he’d never do it again. New online skulduggery resembles his old tricks, and then some.

article.head.headline
Sep 25, 2026
‘Hold My Legs’: How Ernie Sisto Shot a Sky-High Disaster

When a B-25 bomber crashed into the Empire State Building in 1945, a Times photographer leaned far out to get close up.


YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Buzz Online Daily

Spreading good vibes to our readers no matter where you are.

NEWSLETTER